Back to News
Market Impact: 0.15
Tarsus Names Neera Clase Commercial Chief To Expand XDEMVY Reach And Lead Pipeline Planning
Source: Nasdaq
Management & Governance
Tarsus Pharmaceuticals appointed Neera Clase as chief commercial officer, effective November 1, 2026. The article provides no additional details about the appointment or its expected business impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
TARS0.20
More News
- Norwegian shares surge 13% on earnings beat, guidance raise
- ECB’s Lagarde Steps Aside as European Economic Pressure Builds
- Walmart investigates Flipkart over employee kickback claims: Moneycontrol
- Thrive Holdings to acquire ADT for $7.6 billion in cash deal
- Alphabet Miss Revives AI Fears
- Norwegian Cruise Line stock jumps on earnings beat